This study demonstrated that in well-selected patients (women without history of infertility, younger than 35 years old and with basal FSH lower than 15 IU/l) with bilateral stage I BOT, ultra-conservative fertility-sparing approach followed by a fertility programme gives real reproductive advantages. This evidence concerns the gene BRD2 and Infertility.